The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Taizhou Maibotaike Pharmaceutical Co., Ltd., established on 2015-02-04, Business scope includes biological products,Diagnostic reagents,Chemical Biological Reagent,Drug research and development,technical consulting,Technology Transfer and Technical Services(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Import, export and wholesale business involving the above goods and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France.

HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.

Beijing Zhenzhi Medical Technology Co. Ltd. is a company headquartered in China. The firm develops medical technology solutions.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Qingdao China Cyberman Medical Cell Biology Co., Ltd., established on 2019-03-04, Business scope includes research and development of cell drugs;regenerative medicine research;Functional Cell Research;Basic research and application of biomedical technology;New products in the field of biotechnology,New Technology,New technology research and development and industrialization of results;Bioengineering technology project contracting,technical consulting,technology transfer;medicine,Healthy food,Cosmetics and their intermediates,medical materials,Biological Products and Materials,Diagnostic reagents,experimental reagent,medical instruments,Technical research and development of experimental equipment,Technical Services;medicine,Healthy food,sales of cosmetics,beauty service(Does not contain medical behavior)(The above must carry out business activities with the license issued by the competent department);Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations,law,Projects restricted by administrative regulations can only be operated after obtaining a license);Stem Cell Isolation, Culture and Storage,Immune cell isolation culture and storage,health management,Health Information Consultation,Medical service,(issued by the health department<Medical Institution Qualification License>Carry out business activities).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Beijing Huaao Xuande Biomedical Technology Co., Ltd., established on 2022-07-18, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Information Technology Consulting Services;Biochemical product technology research and development;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Hangzhou Tianji Jishi Biotechnology Co., Ltd., established on 2021-08-06, Business scope includes general items:Pharmaceutical commissioned production;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Technology intermediary service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Drug retail;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.